In the two instances studied, mothers of twins showed abnormally high PAPP levels.
INTRODUCTION
Previous studies from our laboratory have revealed the existence of up to four pregnancy-associated plasma proteins (PAPP's)' in women during the 2nd and 3rd trimesters of normal gestation (1, 2) . These proteins differed from each other immunologically and in their physicochemical properties. Three of them were partially purified and were used in the production of monoReceived for publication 22 January 1274 and in revised form 24 April 1974. 'Abbreviations used in this paper: HCG, human chorionic gonadotropin; HPL, human placental lactogen; PAPP, pregnancy-associated protein; RIA, radioimmunoassay; SP1, 2,3, pregnancy-associated proteins described by Bohn (18) . specific antisera (3) . Analogous PAPP's were also found in the rat and mouse, although there was little or no immunological relationship between these proteins of the three species (4) . Other investigators have also described various pregnancy-associated proteins in man by employing several assay methods and/or reagents (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .
One of the PAPP's (PAPP-D) has recently been identified immunologically as human placental lactogen (3, 22) , while another (PAPP-C) was shown to be identical to the pregnancy-specific 91-glycoprotein (SP1) described by Bohn (3, 18) . PAPP-A may represent a heretofore undescribed PAPP, based on published data and on observations obtained in our laboratory showing that it was unrelated immunologically to Bohn's pregnancy-associated proteins, SP2 and SP3, and to Berne's a2-pregnoglobulin (18, 20, 23) . PAPP-B also appears to be unrelated to Bohn's SP2 and SP3 proteins (18) . Based on reports in the literature (18, 21, 23, 24) and unpublished observations in our laboratory, there is reason to believe that the well-known "pregnancy zone" protein is identical to the protein which has been variously designated SP3 Xh, Xm, a2-pregnoglobulin, new serum a-macroglobulin, and the pregnancy-associated globulin (PAG or Pal) (5, 7, 10-12, 18-21, 23) .
In the present study, the relative concentrations of three of the PAPP's (A, C, and D) were determined in plasma from pregnant women during the 2nd and 3rd trimesters. These data may be helpful in designing further definitive experimental studies aimed at better understanding the biological functions and clinical significance of these pregnancy-associated proteins.
METHODS
Pregnancy plasma. 206 samples of pregnancy plasma were obtained from 175 women between 12 and 44 wk of gestation. In 24 cases, 2 samples were from single individuals at different times, while in 4 instances, 3 samples were taken serially. The specimens were stored at -20'C until assayed. A review of the medical records showed that approximately one half of the women had associated pregnancy complications such as hypertension or diabetes mel76The Journal of Clinical Investigation Volume 54 September 1974 576-582
litus. Approximately 60%o of the patients were negro, the remainder being Caucasian. Their ages ranged from 14 to 41 yr. There were two women who delivered twins.
Antibody. A single lot of immunoglobulin concentrate from appropriately absorbed hyperimmune rabbit antisera to human pregnancy plasma was prepared as previously described (1, 2) . It was stored at -20'C in aliquots of 2 ml, which was sufficient for one set of assays. This antibody concentrate failed to show any visible reactions with individual plasmas from 26 nonpregnant normal women and 24 normal men.
Assay. The antibody crossed immunoelectrophoresis method was employed to determine the pregnancy protein concentrations (25, 26) . Warm molten 1% agarose in veronal acetate buffer (ionic strength=0.025, pH 8.6) was introduced by capillarity into a 0.18-cm-thick space between two 5 X 5-cm glass plates. The top plate was carefully removed after the gel had solidified. Three parallel equidistant 3-mm wells and a linear cut 2 mm above the well edges were made simultaneously with a machined device. Samples of plasma (10 Ial) were introduced into the wells while the current was on, after the agarose plates had been equilibrated for 10 min at 2 V/cm in an electrophoresis cell with reservoirs containing the same veronal acetate buffer. Electrophoresis was carried out for exactly 1 h for each plate under these conditions. At this time, the plate was carefully removed and processed for the second electrophoresis. A second linear cut was made 20 mm above the wells, and the agarose gel between this and the earlier cut was removed. A clean 5 X 5-cm glass slide was placed on top of the remaining segments of gel. Warm (50'C) 1% agarose solution containing the antibody concentrate at a final dilution of 1: 10 was introduced between the two glasses as described earlier. After gelling, the top glass was removed with great care. The plates were then subjected to the second electrophoresis overnight (2 V/cm) perpendicular to the first run, with the gel side down and with the anode on the antibody side. Random wells in different plates were charged with four twofold serial dilutions of a reference standard plasma. The latter was a pool of 3rd-trimester pregnancy plasmas that has been concentrated fourfold by lyophilization. After electrophoresis in the second direction, the plates were further developed for 2 days at room temperature. The unstained patterns were photographed with the Cordis Immunodiffusion Camera (Cordis Laboratories, Miami, Fla.) at X 1.8 magnification. Measurements of the precipitin "hills" of the PAPP-A and PAPP-C systems could readily be made from these photographs, but the other two reactions were usually too faint for clear direct visualization. For these (PAPP-B and PAPP-D), the slides were dialyzed and dried after being covered with wet Whatman #1 filter paper to avoid distortion or shrinkage. After removing any lint, the precipitin hills were stained with amido black for measurement. Under these assay conditions, the migration of the PAPP's in the first direction was rather limited, and the precipitin hills approached those seen in the "rocket" technic of Laurell (37) .
Analysis of the patterns obtained with serial dilutions of the reference pregnancy plasma revealed that measurement of the heights of the hills yielded relative quantitative values equivalent to those obtained by planimetry of the areas subtended by them. Both parameters have been used for such quantitation (36) , and in the present study, the height of each system was employed. This value was measured from a line through the centers of the wells to the tips of the hills. The values obtained for each dilution of the reference standard plasma concentrate were plotted on an arithmetric scale, which yielded a straight line in the dilutions tested (1: 2, 1: 4, 1:8, 1:16). An arbitrary concentration of 100 U/ml for each PAPP was assigned to the concentrated reference standard plasma, and the unknown values relative to this reference were read from the standard curves. The latter were run in each experiment. Unit values less than 6 or greater than 50 were roughly estimated by extrapolation of the standard curves.
The four pregnancy protein immune systems in the crossed antibody immunoelectrophoresis had been identified earlier in tests with the purified PAPP's (2, 3) . In the present study, the precipitin hills were readily identified on the basis of their electrophoretic mobilities, their times of appearance, and the characteristics of the precipitin lines. PAPP-A migrated most rapidly, followed closely by PAPP-D. However, the latter developed more slowly than the PAPP-A system, was much fainter, and usually required staining to be visualized. PAPP-C showed a rapidly developing intense and thick line, which migrated well behind PAPP-A and PAPP-D. Although PAPP-B migrated with PAPP-C, the PAPP-B system was delayed in appearance and was very weak in intensity, almost always requiring staining to be seen. For these reasons, the latter was often masked by the PAPP-C reaction and was only clearly seen when its hill was higher than the PAPP-C system. Because of this, PAPP-B could not be analyzed quantitatively in the present study. All samples were tested in duplicate on different occasions. A typical plate and standard curves are shown in Fig. 1 . The accuracy of the method was equivalent to that reported by Clarke and Freeman (26) . In some cases, when the concentration of one of the PAPP's was so high that a complete hill was not produced, the sample was retested by utilizing a higher antibody concentration. The plasma content of human placental lactogen (HPL) was also measured by using a solid phase radioimmunoassay (RIA) procedure (27) . ing rate from the 29th wk until labor. In the cases of PAPP-C and PAPP-D, both appeared to reach plateau values during the late period of gestation.
In the six samples obtained on the day of delivery, PAPP-D levels had dropped precipitously, and this protein was not detectable in five of the six specimens.
This was not the case for PAPP-A, B, and C.
As indicated above, the PAPP-B system often could not be seen regularly unless its hill was higher than the intense PAPP-C hill. Bearing this limitation in mind, the patterns were examined for the presence of PAPP-B, and results are summarized in Table I . It may be noted that PAPP-B was almost never seen under these assay conditions before the 28th wk of gestation. It became detectable in approximately one fourth of the specimens obtained during the 8th mo and was found in one half of the samples at or after 33 wk of gestation.
Attempts were made to determine whether high levels of one PAPP was usually accompanied by high levels of the others during the last month of pregnancy. Analysis of these data revealed very little correlation between the concentrations of the PAPP's in individual samples. r 100.
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60. ranged from -0.011 to 0.298 in various paired comparisons. Thus, as an example, a given specimen might have a quite high PAPP-A but low C and D concentrations. During the last month of gestation, both PAPP-A and PAPP-C in pregnancies with male fetuses were significantly higher than those with female fetuses; no such difference was observed for PAPP-D (Table II) . It was also noted that fetal size influenced PAPP-C concentration. Higher levels of this protein occurred during the last month of gestation in those pregnancies where the infant birth weight was elevated (Fig. 5) . Infant birth weight did not appear to affect the concentrations of PAPP-A or PAPP-D, however. Maternal age, as well as race, bore no relation to the plasma concentrations of any of the PAPP's. There was a tendency for women that had three or more full term or premature pregnancies to reveal low levels of PAPP-A and PAPP-D during the last month of gestation (Table III) . Attempts were made to analyze matched groups with regard to parity, fetal sex, and newborn weight. The same trends seen above were observed in most cases, but the smaller sample sizes sometimes did not show statistical significance. Analysis of the data based on unit weight of the infant (kilograms) also showed the same trends. It (27) . It was also recently found that PAPP-C is immunologically identical to Bohn's pregnancy-specific Pi-glycoprotein, SP1 (18) . The increase in concentration of PAPP-C during pregnancy noted above agrees with limited serial observations made by Bohn in eight normal pregnant women, using radial immunodiffusion with specific anti-SP1 antiserum.
Although PAPP-B could not be readily measured because of the technical reasons mentioned, it was not detected before the 28th wk of gestation, except in one mother with twins. It could very well have been present at low concentrations during this early period, becoming increasingly evident towards the end of pregnancy. These findings support the earlier conclusions based on immunological findings (1, 3) that PAPP-B, as well as the other PAPP's, are unrelated to human chorionic gonadotropin (HCG), since this hormone is known to peak early in pregnancy, subsequently decreasing in concentration. It is unlikely that any of the PAPP's represent human chorionic thyrotropin, because the plasma levels of this hormone also peak early in pregnancy (29) . Quantitation of PAPP-B will be readily feasible when monospecific antibody to this protein is developed.
Although the sample size in the present study was relatively small, analysis of several parameters, such as weight of the newborn, sex of fetus, maternal age, parity, and race, have suggested that some of these factors might be correlated with concentrations of these proteins. It is interesting to note that both PAPP-A and PAPP-C appeared to be slightly elevated in mothers carrying male fetuses, as compared to female fetuses. This was not true for PAPP-D, which confirms findings made by RIA (30) . Although the reasons for such a correlation with fetal sex are not clear, it is worth mentioning that the maternal levels of certain hormones, such as HCG and progesterone, have also been found to be correlated with the sex of the infant (31) (32) (33) . It was also noted that the infant birth weight appears to be correlated with the level of PAPP-C and that increasing parity resulted in lower PAPP-A and PAPP-D levels. Because these preliminary observations included data obtained with samples from women with several complications of pregnancy, further stud-
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T.-M. Lin Although the function of the PAPP's are not known at present, recent studies by Bohn suggest that the pregnancy-specific PAPP-C (SP1) may weakly bind three steroid hormones (estriol, estradiol, and testosterone) (34) . In comparison, he found that his pregnancy-associated glycoproteins, SP2 and SP3, bound these steroids with greater affinity, SP2 showing preferential association for testosterone and estradiol, while SP3 had the greatest affinity for estriol. It should be emphasized that both SP2 and SP3 (a-pregnoglobulin, PAG, etc.) are not specific for pregnancy but are readily detectable in an appreciable proportion of normal individuals and in a large percentage of patients with cancer or in those taking hormonal contraceptives. In fact, Bohn has recently preferred to designate them as acute phase proteins (35) . In contrast, all of the PAPP's described here appear to be generally pregnancy specific, since none of them have been detected by the methods used in nonpregnant normal male or female plasma, in plasma from patients with a variety of cancers not derived from the trophoblast, or in women receiving hormonal contraceptives (3) .
